Pricing
BioSyndex is free for verified accredited investors. Founding issuers list their first private placement at no charge—we do not, and will not, charge investors for access to deals.
We are onboarding a founding issuer cohort. Your first private placement lists free (listing-fee waiver). After that listing, standard issuer plans below will apply when we activate paid tiers—eligibility is tracked per company, not on a calendar deadline.
Verified accredited investors under Rule 506(c)
Freealways
Companies in the founding issuer cohort
Freefirst private placement
Where issuer pricing is headed (Planned — not yet active)
Companies sponsoring a single private placement
$5,000per offering listing
Companies anticipating multiple offerings
$25,000per 12-month term
Yes. Verified accredited investors pay nothing to browse opportunities, access data rooms, or participate through our broker-dealer partner. We do not gate deal access behind a subscription.
A founding issuer is a company we admit to the private founding cohort. Eligibility is tracked per issuer profile—not on a fixed calendar end date. When you are marked as a founding issuer, your first private placement can list at no charge.
Your first private placement listing on BioSyndex is free: the platform listing fee is waived while you complete Precision Diligence, pass review, and open the opportunity to verified accredited investors. It is one waiver per founding issuer company.
After your first listing, the founding waiver is marked used on your issuer profile. Future listings will follow the paid issuer tiers on this page when those tiers are activated. Until then, contact us if you are planning another placement.
We use industry-standard encryption, role-based access, and audit logging. See our Privacy Policy and legal disclaimers for details.
Reg D 506(c) aligned workflows · Accredited investors only · Patent Pending · BioSyndex, Inc. is a technology platform, not a broker-dealer or investment adviser · Legal disclaimers · Accredited investor policy